Skip to content

REPROS THERAPEUTICS INC.

Delisted

CIK 897075fmd_00QZCNZ94SVHJ9BVNSCYGWR919Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 1988 to Sep 30, 2017, 52 periods

Income Statement · Annual · Millions · USD
Line itemFY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016
Total revenues––10000000
Research and development––23391424272413
Interest and investment income––00000000
Net income from continuing operations––(27)(5)(12)(18)(28)–––
Net income(14)(25)(27)(5)(12)(19)(28)(33)(29)(17)
REPROS THERAPEUTICS INC. financial statements · FinancialMD